Lista de obras -

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

artículo científico publicado en 2009

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

artículo científico publicado en 2003

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile

artículo científico publicado en 2012

Baseline CD4+ T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients ⬇️

artículo científico publicado el 1 de enero de 2011

Bronchiolitis Obliterans Organizing Pneumonia Associated with AcuteMycoplasma pneumoniaeInfection ⬇️

artículo científico publicado el 1 de diciembre de 1997

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

artículo científico publicado en 2014

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

article

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir

artículo científico publicado el 1 de enero de 2010

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

artículo científico publicado en 2013

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals

scientific article published on 27 January 2014

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

artículo científico publicado en 2015

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.

artículo científico publicado en 2010

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab

scientific article published on 01 December 2019

Hepatitis C Virus Infection and Progression of Infection Due to Human Immunodeficiency Virus ⬇️

artículo científico publicado el 1 de enero de 1993

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

article

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens ⬇️

artículo científico publicado el 19 de marzo de 2012

Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study

artículo científico publicado en 2019

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

artículo científico publicado en 2016

Short Communication: High Effectiveness of Etravirine in Routine Clinical Practice in Treatment-Experienced HIV Type 1-Infected Patients

article

The Role of Inactive Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Salvage Therapy for Drug-Resistant HIV-1 Infection in the Era of New Classes and New Generation Antiretrovirals

article

The changing face of HIV/AIDS in treated patients

artículo científico publicado en 2009

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

artículo científico publicado en 2015

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.

artículo científico publicado en 2013

Encefalitis con múltiples lesiones cerebrales ocupantes de espacio en un paciente con infección por el virus de la inmunodeficiencia humana tipo 1 ⬇️

artículo científico publicado el 15 de febrero de 2011

Lista de obras de

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial

Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile

Baseline CD4+ T-cell counts and weighted background susceptibility scores strongly predict response to maraviroc regimens in treatment-experienced patients ⬇️

Bronchiolitis Obliterans Organizing Pneumonia Associated with AcuteMycoplasma pneumoniaeInfection ⬇️

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

Do we need genotypic weighted resistance scores for antiretrovirals? The curious case of tipranavir

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia

Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals.

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab

Hepatitis C Virus Infection and Progression of Infection Due to Human Immunodeficiency Virus ⬇️

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

Mutations in the protease gene associated with virological failure to lopinavir/ritonavir-containing regimens ⬇️

Routine screening of anal cytology in HIV-infected subjects and the impact on invasive anal cancer. A prospective cohort study

Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial

Short Communication: High Effectiveness of Etravirine in Routine Clinical Practice in Treatment-Experienced HIV Type 1-Infected Patients

The Role of Inactive Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Salvage Therapy for Drug-Resistant HIV-1 Infection in the Era of New Classes and New Generation Antiretrovirals

The changing face of HIV/AIDS in treated patients

The lipid-lowering effect of tenofovir/emtricitabine: a randomized, crossover, double-blind, placebo-controlled trial

Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir/ritonavir: an exploratory study.

Encefalitis con múltiples lesiones cerebrales ocupantes de espacio en un paciente con infección por el virus de la inmunodeficiencia humana tipo 1 ⬇️